We are live on ! Find out more
PAHC icon

Phibro Animal Health

218 hedge funds and large institutions have $794M invested in Phibro Animal Health in 2025 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 69 increasing their positions, 79 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

104% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 24

52% more capital invested

Capital invested by funds: $521M → $794M (+$273M)

32% more call options, than puts

Call options by funds: $441K | Put options by funds: $335K

12% more funds holding

Funds holding: 194218 (+24)

3.85% less ownership

Funds ownership: 100.17%96.31% (-3.9%)

13% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 79

Holders
218
Holders Change
+24
Holders Change %
+12.37%
% of All Funds
2.86%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
49
Increased
69
Reduced
79
Closed
24
Calls
$441K
Puts
$335K
Net Calls
+$106K
Net Calls Change
+$106K

PAHC Hedge Fund Activity: Q3 2025 in Review

218 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q3 2025, worth a combined $794M — up 52% from $521M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new PAHC positions and 24 closed out — a net gain of 25 holders — while 69 added to existing stakes and 79 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $17.8M. The largest seller was ExodusPoint Capital Management, cutting an estimated $21.9M.

  • 218 institutional investors held Phibro Animal Health (PAHC) as of Q3 2025, up from 194 in Q2 2025.
  • Funds reported $794M of Phibro Animal Health stock for Q3 2025, up 52% quarter-over-quarter.
  • 49 funds opened new Phibro Animal Health positions in Q3 2025 and 24 closed out, a net change of +25 holders.
  • The largest Phibro Animal Health buyer in Q3 2025 was Fidelity Investments, an estimated $17.8M added.
  • The largest Phibro Animal Health seller in Q3 2025 was ExodusPoint Capital Management, an estimated $21.9M sold.

Based on aggregated 13F filings for Q3 2025.